- Report
- December 2020
- 144 Pages
From €2029EUR$2,100USD£1,735GBP
€2898EUR$3,000USD£2,478GBP
- Report
- January 2018
Global
From €4347EUR$4,500USD£3,717GBP
- Report
- June 2021
Global
From €7245EUR$7,500USD£6,195GBP
- Report
- October 2018
Global
From €7245EUR$7,500USD£6,195GBP
- Report
- March 2022
- 110 Pages
Global
€3719EUR$3,850USD£3,180GBP
- Report
- June 2019
- 374 Pages
Global
From €3912EUR$4,050USD£3,345GBP
- Report
- August 2023
- 90 Pages
Global
From €3500EUR$3,881USD£3,098GBP
- Report
- May 2023
- 89 Pages
Global
From €3500EUR$3,881USD£3,098GBP
- Report
- October 2023
- 146 Pages
Global
From €3407EUR$3,528USD£2,914GBP
€4009EUR$4,150USD£3,428GBP
- Book
- April 2014
- 926 Pages
- Book
- May 2024
- 256 Pages
- Book
- January 2022
- 720 Pages
- Book
- May 2014
- 400 Pages
- Book
- March 2015
- 392 Pages
- Book
- September 2013
- 616 Pages
The Extracellular Matrix Patch (ECMP) market is a subset of the biomaterials industry. ECMPs are biocompatible materials that are used to repair or replace damaged tissue. They are composed of natural or synthetic extracellular matrix components, such as collagen, elastin, and glycosaminoglycans. ECMPs are used in a variety of medical applications, including wound healing, tissue engineering, and regenerative medicine.
ECMPs have been used in clinical trials for a variety of conditions, including chronic wounds, diabetic foot ulcers, and burns. They have been shown to be effective in promoting wound healing and tissue regeneration. ECMPs are also being studied for their potential use in treating other conditions, such as cardiovascular disease and cancer.
The ECMP market is expected to grow in the coming years, driven by increasing demand for tissue regeneration and wound healing products. The market is also expected to benefit from advances in technology, such as 3D printing and stem cell therapy.
Some of the major players in the ECMP market include Organogenesis, MiMedx, Integra LifeSciences, and Acelity. Show Less Read more